Renal Hyperfiltration and Systemic Blood Pressure in Patients with Uncomplicated Type 1 Diabetes Mellitus

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Yang, Gary K ^a   Maahs, David M ^b   Perkins, Bruce A ^a   Cherney, David Z I ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF COLORADO DENVER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOHIPPURIC ACID; ALDOSTERONE; INULIN;

ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; FEMALE; GLOMERULUS FILTRATION; GLOMERULUS FILTRATION RATE; HEART RATE; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY BLOOD FLOW; MAJOR CLINICAL STUDY; MALE; PROTEIN DIET; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM INTAKE; SYSTOLIC BLOOD PRESSURE;

ADOLESCENT; ADULT; ALDOSTERONE; ANGIOTENSIN II; BLOOD PRESSURE; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; GLOMERULAR FILTRATION RATE; GLUCOSE CLAMP TECHNIQUE; HEART RATE; HUMANS; HYPERGLYCEMIA; KIDNEY; MALE; RENIN;

EID: 84879807184     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068908     Document Type: Article

References (43)

1. Jerums G, Premaratne E, Panagiotopoulos S, MacIsaac RJ, (2010) The clinical significance of hyperfiltration in diabetes. Diabetologia 53: 2093-2104.
2. Magee GM, Bilous RW, Cardwell CR, Hunter SJ, Kee F, et al. (2009) Is hyperfiltration associated with the future risk of developing diabetic nephropathy? A meta-analysis. Diabetologia 52: 691-697.
3. Ruggenenti P, Porrini EL, Gaspari F, Motterlini N, Cannata A, et al. (2012) Glomerular hyperfiltration and renal disease progression in type 2 diabetes. Diabetes Care 35: 2061-2068.
4. Sasson AN, Cherney DZ, (2012) Renal hyperfiltration related to diabetes mellitus and obesity in human disease. World J Diabetes 3: 1-6.
5. Cherney DZ, Sochett EB, Dekker MG, Perkins BA, (2010) Ability of cystatin C to detect acute changes in glomerular filtration rate provoked by hyperglycaemia in uncomplicated Type 1 diabetes. Diabet Med 27: 1358-1365.
6. Rosolowsky ET, Niewczas MA, Ficociello LH, Perkins BA, Warram JH, et al. (2008) Between hyperfiltration and impairment: demystifying early renal functional changes in diabetic nephropathy. Diabetes Res Clin Pract 82Suppl 1: S46-53.
7. Cherney DZ, Scholey JW, Jiang S, Har R, Lai V, et al. (2012) The Effect of Direct Renin Inhibition Alone and in Combination With ACE Inhibition on Endothelial Function, Arterial Stiffness, and Renal Function in Type 1 Diabetes. Diabetes Care 35: 2324-2330.
8. Sochett EB, Cherney DZ, Curtis JR, Dekker MG, Scholey JW, et al. (2006) Impact of renin angiotensin system modulation on the hyperfiltration state in type 1 diabetes. J Am Soc Nephrol 17: 1703-1709.
9. Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, et al. (1986) Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 77: 1925-1930.
10. Miller JA, Floras JS, Zinman B, Skorecki KL, Logan AG, (1996) Effect of hyperglycaemia on arterial pressure, plasma renin activity and renal function in early diabetes. Clin Sci (Lond) 90: 189-195.
11. Cherney DZ, Miller JA, Scholey JW, Nasrallah R, Hebert RL, et al. (2010) Renal hyperfiltration is a determinant of endothelial function responses to cyclooxygenase 2 inhibition in type 1 diabetes. Diabetes Care 33: 1344-1346.
12. Cherney DZ, Reich HN, Jiang S, Har R, Nasrallah R, et al. (2012) Hyperfiltration and the effect of nitric oxide inhibition on renal and endothelial function in humans with uncomplicated type 1 diabetes mellitus. Am J Physiol Regul Integr Comp Physiol 303: R710-718.
13. Pecis M, Azevedo MJ, Gross JL, (1997) Glomerular hyperfiltration is associated with blood pressure abnormalities in normotensive normoalbuminuric IDDM patients. Diabetes Care 20: 1329-1333.
14. Miller JA, Curtis JR, Sochett EB, (2003) Relationship between diurnal blood pressure, renal hemodynamic function, and the renin-angiotensin system in type 1 diabetes. Diabetes 52: 1806-1811.
15. da Costa Rodrigues T, Pecis M, Azevedo MJ, Esteves JF, Gross JL, (2006) Ambulatory blood pressure monitoring and progression of retinopathy in normotensive, normoalbuminuric type 1 diabetic patients: a 6-year follow-up study. Diabetes Res Clin Pract 74: 135-140.
16. Imano E, Miyatsuka T, Motomura M, Kanda T, Matsuhisa M, et al. (2001) Heart rate elevation and diabetic retinopathy in patients with type 2 diabetes mellitus and normoalbuminuria. Diabetes Res Clin Pract 52: 185-191.
17. Marcovecchio ML, Dalton RN, Schwarze CP, Prevost AT, Neil HA, et al. (2009) Ambulatory blood pressure measurements are related to albumin excretion and are predictive for risk of microalbuminuria in young people with type 1 diabetes. Diabetologia 52: 1173-1181.
18. Cherney DZ, Lai V, Scholey JW, Miller JA, Zinman B, et al. (2010) Effect of direct renin inhibition on renal hemodynamic function, arterial stiffness, and endothelial function in humans with uncomplicated type 1 diabetes: a pilot study. Diabetes Care 33: 361-365.
19. Cherney DZ, Sochett EB, Miller JA, (2005) Gender differences in renal responses to hyperglycemia and angiotensin-converting enzyme inhibition in diabetes. Kidney Int 68: 1722-1728.
20. Cherney DZ, Reich HN, Miller JA, Lai V, Zinman B, et al. (2010) Age is a determinant of acute hemodynamic responses to hyperglycemia and angiotensin II in humans with uncomplicated type 1 diabetes mellitus. Am J Physiol Regul Integr Comp Physiol 299: R206-214.
21. Cherney DZ, Miller JA, Scholey JW, Bradley TJ, Slorach C, et al. (2008) The effect of cyclooxygenase-2 inhibition on renal hemodynamic function in humans with type 1 diabetes. Diabetes 57: 688-695.
22. Davidson WD, Sackner MA, (1963) Simplification of the Anthrone Method for the Determination of Inulin in Clearance Studies. J Lab Clin Med 62: 351-356.
23. Jung K, Klotzek S, Schulze BD, (1990) Refinements of assays for low concentrations of inulin in serum. Nephron 54: 360-361.
24. Florijn KW, Barendregt JN, Lentjes EG, van Dam W, Prodjosudjadi W, et al. (1994) Glomerular filtration rate measurement by "single-shot" injection of inulin. Kidney Int 46: 252-259.
25. Hopkins PN, Lifton RP, Hollenberg NK, Jeunemaitre X, Hallouin MC, et al. (1996) Blunted renal vascular response to angiotensin II is associated with a common variant of the angiotensinogen gene and obesity. J Hypertens 14: 199-207.
26. Cherney DZ, Lai V, Miller JA, Scholey JW, Reich HN, (2010) The angiotensin II receptor type 2 polymorphism influences haemodynamic function and circulating RAS mediators in normotensive humans. Nephrol Dial Transplant 25: 4093-4096.
27. Miller JA, (1999) Impact of hyperglycemia on the renin angiotensin system in early human type 1 diabetes mellitus. J Am Soc Nephrol 10: 1778-1785.
28. Ficociello LH, Perkins BA, Roshan B, Weinberg JM, Aschengrau A, et al. (2009) Renal hyperfiltration and the development of microalbuminuria in type 1 diabetes. Diabetes Care.
29. Chillaron JJ, Sales MP, Flores-Le-Roux JA, Murillo J, Benaiges D, et al. (2011) Insulin resistance and hypertension in patients with type 1 diabetes. J Diabetes Complications 25: 232-236.
30. Sowers JR, Epstein M, (1995) Diabetes mellitus and associated hypertension, vascular disease, and nephropathy. An update. Hypertension 26: 869-879.
31. Vervoort G, Veldman B, Berden JH, Smits P, Wetzels JF, (2005) Glomerular hyperfiltration in type 1 diabetes mellitus results from primary changes in proximal tubular sodium handling without changes in volume expansion. Eur J Clin Invest 35: 330-336.
32. Torbjornsdotter TB, Jaremko GA, Berg UB, (2004) Nondipping and its relation to glomerulopathy and hyperfiltration in adolescents with type 1 diabetes. Diabetes Care 27: 510-516.
33. Christiansen EH, Molgaard H, Christensen PD, Sorensen KE, Christensen CK, et al. (1998) Increased left ventricular systolic function in insulin dependent diabetic patients with normal albumin excretion. Eur Heart J 19: 1735-1739.
34. Floras JS, Hara K, (1993) Sympathoneural and haemodynamic characteristics of young subjects with mild essential hypertension. J Hypertens 11: 647-655.
35. Ritz E, Rump LC, (2007) Do beta-blockers combined with RAS inhibitors make sense after all to protect against renal injury? Curr Hypertens Rep 9: 409-414.
36. Thulesen J, Poulsen SS, Jorgensen PE, Nexo E, (1999) Adrenergic blockade in diabetic and uninephrectomized rats: effects on renal size and on renal and urinary contents of epidermal growth factor. Nephron 81: 172-182.
37. Jacobsen P, Rossing K, Hansen BV, Bie P, Vaag A, et al. (2003) Effect of short-term hyperglycaemia on haemodynamics in type 1 diabetic patients. J Intern Med 254: 464-471.
38. Cherney DZ, Sochett EB, Lai V, Dekker MG, Slorach C, et al. (2010) Renal hyperfiltration and arterial stiffness in humans with uncomplicated type 1 diabetes. Diabetes Care 33: 2068-2070.
39. Price DA, Porter LE, Gordon M, Fisher ND, De'Oliveira JM, et al. (1999) The paradox of the low-renin state in diabetic nephropathy. J Am Soc Nephrol 10: 2382-2391.
40. Kikkawa R, Kitamura E, Fujiwara Y, Haneda M, Shigeta Y, (1986) Biphasic alteration of renin-angiotensin-aldosterone system in streptozotocin-diabetic rats. Ren Physiol 9: 187-192.
41. Kalinyak JE, Sechi LA, Griffin CA, Don BR, Tavangar K, et al. (1993) The renin-angiotensin system in streptozotocin-induced diabetes mellitus in the rat. J Am Soc Nephrol 4: 1337-1345.
42. Rosenberg ME, Smith LJ, Correa-Rotter R, Hostetter TH, (1994) The paradox of the renin-angiotensin system in chronic renal disease. Kidney Int 45: 403-410.
43. Harrison-Bernard LM, (2009) The renal renin-angiotensin system. Adv Physiol Educ 33: 270-274.